Fluence Energy Inc. Class A Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Fluence Energy Inc. Class A Common Stock trades at $6.15 (market cap $969.93M), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Vir Biotechnology Inc. Common Stock is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Fluence Energy Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Fluence Energy Inc. Class A Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| FLNC | VIR | |
|---|---|---|
Market Cap | $969.93M | $1.80B |
Volume | 7,001,648 | 1,782,836 |
Sector | Utilities | Health |
52-Week High | $32.23 | $11.78 |
52-Week Low | $6.21 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.02B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Fluence Energy Inc. designs and delivers energy storage products, operational services, and asset optimization software for renewable-energy and storage applications worldwide.
Read more on FLNC →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →